1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The hemato oncology testing market is adapting to a new era driven by advanced technologies and increasingly complex clinical needs. Senior decision-makers face rapid developments in diagnostics, transforming approaches to blood cancer detection and patient care.
Market Snapshot: Hemato Oncology Testing Market
The global hemato oncology testing market is demonstrating significant expansion. The market grew from USD 4.36 billion in 2024 to USD 5.07 billion in 2025, with a projected CAGR of 16.17%, reaching USD 10.73 billion by 2030. This growth reflects a robust demand for precision diagnostics amid rising blood cancer incidence.
Scope & Segmentation
This analysis delivers a comprehensive breakdown of the market’s strategic components, focused on both technology and end-user perspectives. The segmentation framework supports actionable planning for companies seeking tailored positioning:
- Sample Types: Bone marrow evaluations, peripheral blood assays, and tissue biopsy procedures, each bringing distinct workflow and insight requirements.
- Technologies: Flow cytometry for cell identification and disease monitoring; fluorescence in situ hybridization for gene and chromosomal analysis; immunohistochemistry using chromogenic or fluorescent markers; next generation sequencing enabling gene, exome, and genome interrogation; and polymerase chain reaction methods spanning digital, quantitative, and reverse transcription formats.
- Clinical Applications: Leukemia (including acute and chronic subtypes), lymphoma (Hodgkin and non-Hodgkin), myelodysplastic syndrome, and myeloma; all demand specific molecular and cytogenetic profiling.
- End Users: Academic and research centers, diagnostic laboratories, hospitals and clinics integrating diagnostics, and research institutes driving translational studies.
- Regional Coverage: Americas (with focused data on the United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (including key markets such as the United Kingdom, Germany, France, and others), and Asia-Pacific (notably China, India, Japan, Australia, and more).
- Company Analysis: Insights on leading participants such as F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation, Sysmex Corporation, QIAGEN N.V., bioMérieux SA, Agilent Technologies, Inc., and Illumina, Inc.
Key Takeaways: Hemato Oncology Testing Market
- Molecular profiling and next generation sequencing are redefining diagnostic frameworks, supporting the personalized medicine movement in hemato oncology.
- Automated immunophenotyping and multiplexed assays are expanding clinical visibility into disease progression and therapeutic responses.
- Cross-disciplinary collaboration between laboratory scientists, bioinformaticians, and clinical teams is accelerating validation, quality assurance, and innovation.
- Investment in data analytics platforms and artificial intelligence is enabling greater diagnostic precision, predictive modeling, and more reliable clinical decision support.
- Regulators are streamlining pathways for in vitro diagnostics, enabling faster access for innovations demonstrating analytical performance and utility.
- Regional strategies must consider infrastructure maturity, healthcare policy, reimbursement structures, and local manufacturing to maintain resilience in evolving policy landscapes.
Tariff Impact
Evolving trade policies and import tariffs are affecting procurement costs across the United States. These pressures are leading laboratories and manufacturers to shift toward domestic sourcing, invest in local production, and diversify vendor relationships to safeguard against supply interruptions and price instability.
Methodology & Data Sources
Primary research involved in-depth interviews with clinical experts, laboratory leaders, and industry executives. This was combined with secondary analysis of peer-reviewed publications, regulatory documents, and financial disclosures. Validation included data triangulation, quantitative analysis, and strict ethical standards throughout.
Why This Report Matters
- Empowers decision-makers with actionable segmentation and regional insights to guide investment and commercial strategy.
- Enables effective navigation of technology advancement, regulatory complexity, and evolving procurement dynamics in hemato oncology diagnostics.
Conclusion
A convergence of technology, clinical collaboration, and strategic adaptation is reshaping hemato oncology testing. Forward-thinking organizations leveraging data-driven approaches and cross-sector partnerships are best positioned to advance patient care and build sustainable growth.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of high-sensitivity circulating tumor DNA assays for real-time minimal residual disease monitoring
5.2. Integration of next-generation sequencing panels into routine hemato oncology diagnostics for personalized therapy
5.3. Adoption of AI-powered digital image analysis for enhanced blood smear and bone marrow evaluation in leukemia
5.4. Standardization of multi-parameter flow cytometry protocols to improve immunophenotyping accuracy across laboratories
5.5. Development of point-of-care molecular platforms for rapid detection of leukemic driver mutations at bedside
5.6. Expansion of multi-omics approaches combining genomics transcriptomics and proteomics in hematological malignancy testing
5.7. Regulatory challenges and reimbursement strategies driving adoption of novel companion diagnostics in blood cancers
5.8. Emergence of automated digital pathology solutions to streamline histopathological assessment in hemato oncology
5.2. Integration of next-generation sequencing panels into routine hemato oncology diagnostics for personalized therapy
5.3. Adoption of AI-powered digital image analysis for enhanced blood smear and bone marrow evaluation in leukemia
5.4. Standardization of multi-parameter flow cytometry protocols to improve immunophenotyping accuracy across laboratories
5.5. Development of point-of-care molecular platforms for rapid detection of leukemic driver mutations at bedside
5.6. Expansion of multi-omics approaches combining genomics transcriptomics and proteomics in hematological malignancy testing
5.7. Regulatory challenges and reimbursement strategies driving adoption of novel companion diagnostics in blood cancers
5.8. Emergence of automated digital pathology solutions to streamline histopathological assessment in hemato oncology
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Hemato Oncology Testing Market, by Sample Type
8.1. Introduction
8.2. Bone Marrow
8.3. Peripheral Blood
8.4. Tissue Biopsy
8.2. Bone Marrow
8.3. Peripheral Blood
8.4. Tissue Biopsy
9. Hemato Oncology Testing Market, by Technology
9.1. Introduction
9.2. Flow Cytometry
9.2.1. Immunophenotyping
9.2.2. Minimal Residual Disease Analysis
9.3. Fluorescence In Situ Hybridization
9.3.1. Chromosomal Abnormality Detection
9.3.2. Gene Fusion Detection
9.4. Immunohistochemistry
9.4.1. Chromogenic Immunohistochemistry
9.4.2. Fluorescent Immunohistochemistry
9.5. Next Generation Sequencing
9.5.1. RNA Sequencing
9.5.2. Targeted Gene Sequencing
9.5.3. Whole Exome Sequencing
9.5.4. Whole Genome Sequencing
9.6. Polymerase Chain Reaction
9.6.1. Digital PCR
9.6.2. Quantitative PCR
9.6.3. Reverse Transcription PCR
9.2. Flow Cytometry
9.2.1. Immunophenotyping
9.2.2. Minimal Residual Disease Analysis
9.3. Fluorescence In Situ Hybridization
9.3.1. Chromosomal Abnormality Detection
9.3.2. Gene Fusion Detection
9.4. Immunohistochemistry
9.4.1. Chromogenic Immunohistochemistry
9.4.2. Fluorescent Immunohistochemistry
9.5. Next Generation Sequencing
9.5.1. RNA Sequencing
9.5.2. Targeted Gene Sequencing
9.5.3. Whole Exome Sequencing
9.5.4. Whole Genome Sequencing
9.6. Polymerase Chain Reaction
9.6.1. Digital PCR
9.6.2. Quantitative PCR
9.6.3. Reverse Transcription PCR
10. Hemato Oncology Testing Market, by Application
10.1. Introduction
10.2. Leukemia
10.2.1. Acute Lymphoblastic Leukemia
10.2.2. Acute Myeloid Leukemia
10.2.3. Chronic Lymphocytic Leukemia
10.2.4. Chronic Myeloid Leukemia
10.3. Lymphoma
10.3.1. Hodgkin Lymphoma
10.3.2. Non Hodgkin Lymphoma
10.4. Myelodysplastic Syndrome
10.5. Myeloma
10.2. Leukemia
10.2.1. Acute Lymphoblastic Leukemia
10.2.2. Acute Myeloid Leukemia
10.2.3. Chronic Lymphocytic Leukemia
10.2.4. Chronic Myeloid Leukemia
10.3. Lymphoma
10.3.1. Hodgkin Lymphoma
10.3.2. Non Hodgkin Lymphoma
10.4. Myelodysplastic Syndrome
10.5. Myeloma
11. Hemato Oncology Testing Market, by End User
11.1. Introduction
11.2. Academic & Research Centers
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Research Institutes
11.2. Academic & Research Centers
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Research Institutes
12. Americas Hemato Oncology Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Hemato Oncology Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Hemato Oncology Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche AG
15.3.2. Abbott Laboratories
15.3.3. Siemens Healthineers AG
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. Danaher Corporation
15.3.6. Sysmex Corporation
15.3.7. QIAGEN N.V.
15.3.8. bioMérieux SA
15.3.9. Agilent Technologies, Inc.
15.3.10. Illumina, Inc.
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche AG
15.3.2. Abbott Laboratories
15.3.3. Siemens Healthineers AG
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. Danaher Corporation
15.3.6. Sysmex Corporation
15.3.7. QIAGEN N.V.
15.3.8. bioMérieux SA
15.3.9. Agilent Technologies, Inc.
15.3.10. Illumina, Inc.
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HEMATO ONCOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HEMATO ONCOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HEMATO ONCOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HEMATO ONCOLOGY TESTING MARKET: RESEARCHAI
FIGURE 24. HEMATO ONCOLOGY TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. HEMATO ONCOLOGY TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. HEMATO ONCOLOGY TESTING MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HEMATO ONCOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HEMATO ONCOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HEMATO ONCOLOGY TESTING MARKET: RESEARCHAI
FIGURE 24. HEMATO ONCOLOGY TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. HEMATO ONCOLOGY TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. HEMATO ONCOLOGY TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEMATO ONCOLOGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOPHENOTYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOPHENOTYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL ABNORMALITY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL ABNORMALITY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY GENE FUSION DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY GENE FUSION DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOGENIC IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOGENIC IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENT IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENT IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TARGETED GENE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TARGETED GENE SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HODGKIN LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HODGKIN LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NON HODGKIN LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NON HODGKIN LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 154. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 155. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 158. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 159. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 160. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 161. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 162. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 163. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 166. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 167. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 168. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 169. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 182. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 183. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 188. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 189. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 190. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 191. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 294. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 295. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 296. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 297. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 300. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 301. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 302. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 303. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 306. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOPHENOTYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOPHENOTYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL ABNORMALITY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL ABNORMALITY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY GENE FUSION DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY GENE FUSION DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOGENIC IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHROMOGENIC IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENT IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENT IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TARGETED GENE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TARGETED GENE SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HODGKIN LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HODGKIN LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NON HODGKIN LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NON HODGKIN LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 154. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 155. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 158. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 159. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 160. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 161. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 162. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 163. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 166. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 167. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 168. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 169. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 182. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 183. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 188. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 189. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 190. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 191. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 294. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 295. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 296. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 297. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 300. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 301. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2018-2024 (USD MILLION)
TABLE 302. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY LYMPHOMA, 2025-2030 (USD MILLION)
TABLE 303. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 306. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE
Samples
LOADING...
Companies Mentioned
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Sysmex Corporation
- QIAGEN N.V.
- bioMérieux SA
- Agilent Technologies, Inc.
- Illumina, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | August 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 5.07 Billion |
| Forecasted Market Value ( USD | $ 10.73 Billion |
| Compound Annual Growth Rate | 16.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
